Biogen Idec is committed to conducting our business ethically and with integrity. It’s essential to sustaining our growth and success as a company and to maintaining the trust and confidence of our stakeholders. This extends throughout all aspects of our business, from the way we conduct clinical trials to the way we market our products.
Regulatory agencies worldwide mandate the testing of potential therapeutics in animals to assess their safety and efficacy before they can be tested in humans. Biogen Idec is committed to meeting or exceeding all applicable animal welfare regulations and has established Institutional Animal Care and Use Committees to provide oversight for animal care and use at our facilities . For more information, please see our 2012 Corporate Citizenship Report.
PROVIDING PAYMENTS TO INVESTIGATORS
To ensure the integrity of our research, we employ stringent guidelines in identifying and contracting with investigators (physicians and other personnel) who implement the clinical trials sponsored by Biogen Idec. For more information, please see our 2012 Corporate Citizenship Report.
Biogen Idec is committed to providing information that is accurate, supported by scientific evidence and presented honestly and fairly in every context. For more information, please see our 2012 Corporate Citizenship Report.
PRODUCT SECURITY AND BRAND PROTECTION
Biogen Idec takes the issue of counterfeit, adulterated and compromised drugs very seriously. As part of our commitment to patients, we are dedicated to protecting the safety and integrity of our products . For more information, please see our 2012 Corporate Citizenship Report.